Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enobosarm in metastatic breast cancer
NCT04869943Phase 3Terminated
- Sponsor
- Veru Inc.
- Start
- Oct 2021
- Primary completion
- Jan 2024
- Countries
- 4
01
Overview
A Phase 3 trial of enobosarm in breast cancer, sponsored by Veru Inc.. Started Oct 2021; status: terminated.
02
Drugs
enobosarm
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04869943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04869943.